Sunesis: Q1 Earnings Snapshot
Posted June 18, 2021 5:58 am.
Last Updated June 18, 2021 6:03 am.
CARDIFF, Calif. (AP) _ Viracta Therapeutics, Inc. (VIRX) on Wednesday reported a loss of $79.2 million in its first quarter.
On a per-share basis, the Cardiff, California-based company said it had a loss of $5.22. Earnings, adjusted for non-recurring costs, were 38 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.
Sunesis shares have risen 73% since the beginning of the year. The stock has fallen 42% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIRX at https://www.zacks.com/ap/VIRX
The Associated Press
